CLNN Latest Press Releases

-- June 22, 2026 --

Novel Patented Myelin Drug-Discovery Strategy Targets Massive Unmet Need in Multiple Sclerosis Globe Newswire 8:30 AM

-- May 14, 2026 --

Clene Reports First Quarter 2026 Financial Results and Recent Operating Highlights Globe Newswire 8:00 AM

-- May 6, 2026 --

Presenting on Emerging Growth Conference 92 Day 2 on May 7; Register to live stream Globe Newswire 7:00 AM

-- May 5, 2026 --

Clene Announces $7 Million Underwritten Offering of Common Stock Globe Newswire 8:45 AM

Clene to Present at Upcoming May Conferences Globe Newswire 8:00 AM

Presenting on Emerging Growth Conference 92 Day 1 on May 6; Register to live stream Globe Newswire 7:00 AM

-- May 4, 2026 --

After Successful FDA Meeting, Clene Filing Accelerated Approval NDA for ALS Globe Newswire 8:00 AM

-- March 12, 2026 --

Clene Reports Full Year 2025 Financial Results and Recent Operating Highlights Globe Newswire 8:00 AM

-- February 25, 2026 --

Presenting on Emerging Growth Conference 90 Day 2 on February 26; Register to live stream Globe Newswire 7:00 AM

-- February 24, 2026 --

Clene Issues Stockholder Letter Highlighting Upcoming CNM-Au8 2026 Catalysts Globe Newswire 8:00 AM

Presenting on Emerging Growth Conference 90 Day 1 on February 25; Register to live stream Globe Newswire 7:00 AM

-- February 19, 2026 --

Clene to Present at the Emerging Growth Conference Globe Newswire 8:30 AM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software